Keywords: nautilus, oral, protein, drugs, horizon, biotech, privately-held

Nautilus: oral protein drugs on the horizon?

Article | 01 May 2006

Nautilus Biotech AS, a privately-held French biotechnology company developing next-generation therapeutic proteins, has presented strong data from in vivo studies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Alpha

Prolastin

Go to drug listing